MODERN COMBINATION DRUGS IN THE TREATMENT OF PATIENTS WITH VARIOUS TYPES OF RHINITIS
https://doi.org/10.21518/2079-701X-2016-9-48-52
Abstract
The paper summarizes findings on the place of decongestants in current treatment approaches for various types of rhinitis, their benefits and disadvantages, as well as feasibility of combination with drugs in other pharmacological groups, in particular with the anticholinergic drug ipratropium bromide. Indications for use of xylometazoline in combination with ipratropium bromide are substantiated. The reviewed literature demonstrates that clinical use of the combination scheme with equal effectiveness in eliminating nasal congestion allows to significantly decrease rhinorrhea.
About the Authors
M. A. EDZHE
MSUMD named after A.I. Evdokimov
Russian Federation
PhD in medicine
Russian Federation
PhD in medicine
A. Y. ОVCHINNIKOV
MSUMD named after A.I. Evdokimov
Russian Federation
MD, Prof.
Russian Federation
MD, Prof.
References
1. Международный консенсус в лечении аллергического ринита (Версия Европейской Академии аллергологии и клинической иммунологии, 2000). Рос. ринол., 2000, 3: 5-23. / Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology, 2000. Ros. Rinol., 2000; 3: 5-23.
2. Ramey JT, Bailen E, Lockey RF. Rhinitis medicamentosa. J. Investig Allergol. Clin Immunol., 2006, 16(3): 148-155.
3. Овчинников А.Ю., Эдже М.А., Хон Е.М. Оптимизация лечения больных аллергическим ринитом. РМЖ, 2016, 4: 221- 225. / Ovchinnikov A.Y., Edzhe M.A., Khon E.M. Optimization of treatment of patients with allergic rhinitis. RMZ, 2016, 4: 221-225.
4. Haenisch B, Walstab J, Herberhold S, Bootz F, Tschaikin M, Ramseger R, Bönisch H. Alphaadrenoceptor agonistic activity of oxymetazoline and xylometazoline. Fundam Clin Pharmacol, 2010, 24(6): 729-39.
5. Van Megen YJB, Klaassen ABM, Rodrigues de Miranda JF, van Ginneken CAM, Wentges BTR. Alterations of adrenoceptors in the nasal mucosa of allergic patients in comparison with nonallergic individuals. J. Allergy Clin. Immunol., 1991, 87: 530-540.
6. Кнорре Д.Г., Мызина С.Д. Биологическая химия. 3. Москва: Высшая школа, 2000. 479 с. / Knorre D.G., Myzina S.D. Biological Chemistry. 3. Moscow: Vysshaya Shkola, 2000. 479 p.
7. Chiba Y, Matsuo K, Sakai H, Abe K, Misawa M. Regional differences in vascular responsiveness of nasal mucosae isolated from naive guinea pigs. Auris Nasus Larynx, 2007, 34: 197-201.
8. Corboz MR, Rivelli MA, Varty LM. Pharmacological characterization of postjunctional a- adrenoceptor in human nasal mucosa. Am. J. Rhinol., 2005, 19: 495-502. 9. Arikan OK, Okarsu C, Unal B, Ergin A, Koç C. Effect of oxymetazoline nasal spray on intraocular pressure and retrobulbar hemodynamics. J. Otolaryngol., 2006, 35(Iss. 1): 30-35.
9. Petruson B, Hansson H. Function and structure of nasal mucosa after 6 weeks use of nose-drops. Acta Otolaryngol, 1982, 94(Iss. 5–6): 563-569.
10. Watanabe H, Foo TH, Djazaeri B, Duncombe P, Mackay IS, Durham SR. Oxymetasoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis. Rhinology, 2003, 41(Iss. 3): 167-174.
11. Scarupa MD, Sveum RJ, Schoenwetter WF, Kaliner MA. Anticholinergic agents, uaifenesin and decongestants in the treatment of rhinitis. Second edition. In: Kaliner M.A., editor, Current reviews of rhinitis. Philadelphia, Pa: Current Medicine, Inc, 2002.
12. Свистушкин В.М. Никифорова Г.Н. Возможности комбинации ипратропия бромида и ксилометазолина в лечении больных ринитами. РМЖ, 2013, 11: 583. / Svistushkin V.M. Nikiforova G.N. Prospects for combining ipratropium bromide and xylometazoline in the treatment of patients with rhinitis. RMZ, 2013, 11: 583.
13. Eccles R, Pedersen A, Regberg D, Tulento H, Borum P, Stjärne P. Efficacy and safety of topical combinations of ipratopium and xylometazoline for the treatment of symptoms of runny nose and nasal congestion associated with acute upper respiratory tract infection. Am Rhinol., 2007, 21: 40-45.
Review
For citations:
EDZHE MA, ОVCHINNIKOV AY. MODERN COMBINATION DRUGS IN THE TREATMENT OF PATIENTS WITH VARIOUS TYPES OF RHINITIS. Meditsinskiy sovet = Medical Council. 2016;(9):48-52. (In Russ.) https://doi.org/10.21518/2079-701X-2016-9-48-52
Views:
569
Email this article 